Diabetes

The American Association of Clinical Endocrinology 2023 annual meeting kicks off Thursday with a number of new session formats designed to promote conversation and encourage participation from attendees.

SAN DIEGO — Gerald W. Smetana, MD, MACP, provided an update on three new treatments that are important to primary care physicians.

More than 80% of adults with diabetes using continuous glucose monitoring reported at least one instance of needing to stop using their device due to medical care or a device-related problem, according to survey findings.

Dietary patterns focused on eating more whole grains, vegetables, fruits, legumes, nuts and seeds are best for the management of diabetes, according to an updated guideline published in Diabetologia.

A novel endoscopic procedure combined with semaglutide may eliminate the need for insulin while improving glycemic control and metabolic parameters among patients with type 2 diabetes.

In women with ischemic heart disease, poor fitness and metabolic syndrome with or without diabetes independently drive risks for obstructive coronary artery disease, long-term adverse events and all-cause mortality, researchers reported.

A bill proposed in the U.S Senate would limit out-of-pocket insulin costs for Americans with diabetes who have commercial health insurance, according to a press release.

The antiarrhythmic benefits of empagliflozin in patients with and without diabetes may be explained by the SGLT2 inhibitor’s ability to improve left atrial strain reservoir and contraction phase values, researchers reported.

Patients with type 2 diabetes who undergo metformin therapy demonstrate a 24% lower risk for osteoarthritis, compared with those who received sulfonylurea, according to data published in JAMA Network Open.